BSEBoard Meeting4d ago · 9 Aug 2026, 06:37 pm

Dolphin Medical Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Board Meeting Intimation ....

Dolphin Medical Services Ltd · 526504

✦ AI SummaryResults

Dolphin Medical Services Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026, inter alia, to consider and approve the unaudited standalone financial results of the Company for the 1st quarter ended June 30, 2026 of the Financial Year 2026-27.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Dolphin Medical Services Ltd - 526504 - Board Meeting Intimation for BM Intimation For BM Is Scheduled To Be Held On Thursday, August 14, 2026, Inter Alia, To Consider & Approve The Unaudited Standalone Financial Results Of The Company For The 1St Quarter Ended June 30, 2026 Of The Financial Year 2026-27

Attachments (1)

📄

02589072-5ca3-4935-b1be-ccd7bb695c18.pdf

pdf

Download →
View document text
To Date: 8/9/2026 The Manager Department of Corporate Services Bombay Stock Exchange Limited Phiroze Jeejeebhoy Towers Dalal Street MUMBAI - 400 001. Scrip Code: 526504, DOLPHIN MEDICAL SERVICES LIMITED Ref: Regulation 29(1) of Securities and·Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations"). Dear Sir/Madam, Pursuant to Regulation 29(1) of the SEBI Listing Regulations, this is to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, August 14, 2026, inter alia, to consider & approve the Unaudited Standalone Financial Results of the Company for the 1st Quarter ended June 30, 2026 of the Financial Year 2026-27. Further, in continuation to our earlier intimation dated June 26,2026, in compliance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and the Company's "Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading in Securities by Insiders", the Trading Window for dealing in the securities of the Company for all the Designated Persons, including Insiders, had already been closed with effect from July 01, 2026, and will remain closed till 48 hours after the publication of the financial results. Thanking you, Yours faithfully for DOLPHIN MEDICAL SERVICES LIMITED Mallour Rajesh Kumar Director DIN:08125774